Citation Impact
Citing Papers
Reactive oxygen species at the crossroads of inflammasome and inflammation
2014
Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis
2015
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Meta-analysis of genetic polymorphisms in programmed cell death 1
2014
Macrophages in immunoregulation and therapeutics
2023 Standout
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
2019
The biology and function of fibroblasts in cancer
2016 Standout
Mitochondrial reactive oxygen species and inflammation: Molecular mechanisms, diseases and promising therapies
2016
Systemic sclerosis
2017 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Role of interleukin-6 in cancer progression and therapeutic resistance
2016
Pyroptosis: mechanisms and diseases
2021 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Current views on the function of the lymphatic vasculature in health and disease
2010
Pyroptosis: A new frontier in cancer
2019 Standout
Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway
2012
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense
2018
Perception of self: distinguishing autoimmunity from autoinflammation
2015
Targeting Innate Immunity in Cancer Therapy
2021
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Genetic and epigenetic abnormalities in systemic sclerosis
2016
Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment
2017
Endometriosis
2020 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
The Role of Damage-Associated Molecular Patterns in Human Diseases : Part I - Promoting inflammation and immunity
2015
Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)
2019
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
2016
Works of Kun Mu being referenced
Deregulated NLRP3 and NLRP1 Inflammasomes and Their Correlations with Disease Activity in Systemic Lupus Erythematosus
2013
Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual‐colour fluorescence in‐situ hybridization
2011
Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
2013
Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome
2015
Lymphangiogenesis in gastric carcinoma correlates with prognosis
2009
Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
2006
Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population.
2011
Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway
2016